Resources from the same session
Welcome and Introduction
Presenter: Eva Muñoz Couselo
Session: Bristol Myers Squibb - The Changing Paradigm of Melanoma Treatment: A Clinical Update for 2023
Resources:
Webcast
Current and Emerging Neoadjuvant Treatment Options for Resectable Melanoma
Presenter: Sapna Patel
Session: Bristol Myers Squibb - The Changing Paradigm of Melanoma Treatment: A Clinical Update for 2023
Resources:
Webcast
Panel Discussion: Factors Impacting Treatment Selection for Resectable Melanoma
Presenter: All Speakers
Session: Bristol Myers Squibb - The Changing Paradigm of Melanoma Treatment: A Clinical Update for 2023
Resources:
Webcast
Evidence-Based Considerations for the First-Line Treatment of Metastatic Melanoma
Presenter: Dirk Schadendorf
Session: Bristol Myers Squibb - The Changing Paradigm of Melanoma Treatment: A Clinical Update for 2023
Resources:
Webcast
Summary and Close
Presenter: Eva Muñoz Couselo
Session: Bristol Myers Squibb - The Changing Paradigm of Melanoma Treatment: A Clinical Update for 2023
Resources:
Webcast